Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.

about

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.

Item

http://www.wikidata.org/entity/Q47100706

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Age-associated and therapy-ind ...... nment of experimental gliomas.

@en

Age-associated and therapy-ind ...... nment of experimental gliomas.

@nl

type

Item

label

Age-associated and therapy-ind ...... nment of experimental gliomas.

@en

Age-associated and therapy-ind ...... nment of experimental gliomas.

@nl

prefLabel

Age-associated and therapy-ind ...... nment of experimental gliomas.

@en

Age-associated and therapy-ind ...... nment of experimental gliomas.

@nl

P1476

Age-associated and therapy-ind ...... nment of experimental gliomas.

@en

P2093

Birthe Lohmann

http://www.w3.org/2001/XMLSchema#string

Elisabeth J Rushing

http://www.w3.org/2001/XMLSchema#string

Hannah Schneider

http://www.w3.org/2001/XMLSchema#string

Hans-Georg Wirsching

http://www.w3.org/2001/XMLSchema#string

Karl Frei

http://www.w3.org/2001/XMLSchema#string

Kathy Hasenbach

http://www.w3.org/2001/XMLSchema#string

Martin Pruschy

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma

Hallmarks of Cancer: The Next Generation

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

The role of myeloid cells in the promotion of tumour angiogenesis

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

Regulation of tumor growth and metastasis: the role of tumor microenvironment.

P304

87124-87135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19894

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Weller

Ghazaleh Tabatabai

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29152068

http://www.w3.org/2001/XMLSchema#string

P932

5675620

http://www.w3.org/2001/XMLSchema#string